GSK looks to dominate in new disease areas; FDA chief talks drug pricing policy with biotech leaders

Taking stock of the drug industry, from the lab to the medicine chest

June 7, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Desiree Rios for STAT; Photo illustration Alex Hogan/STAT STAT+ | After missing vaccine glory in pandemic, GSK looks to dominate other diseases With an RSV vaccine now approved, GSK's Phil Dormitzer points to the company's other targets, including pneumonia and herpes. By Jason Mast STAT+ | 'We don't agree' on drug pricing policy, FDA chief tells biotech leaders Robert Califf expressed little sympathy for the drug industry's resistance to parts of the Inflation Reduction Act. By Jason Mast STAT+ | Democrats blast Biden administration over Alzheimer's drug plans Democrats are ratcheting up their criticism of how the Biden administration is planning to handle a potential approval of a new Alzheimer's treatment. By Rachel Cohrs Adam Feuerstein/STAT STAT+ | ASCO showcased the payoff for new cancer medicines: longer lives The biggest example came with results of Tagrisso in non-small cell lung cancer. There was new support, too, for CAR-T therapy. By Matthew Herper and Angus Chen and Adam Feuerstein and Katherine MacPhail GSK's RSV vaccine wins European approval With the European approval, the company now has to reach reimbursement deals in each country in the European Union.  By Andrew Joseph CDC comes under fire for inadequate information about its Covid response As Republicans blasted the agency, a GAO official also said it wasn't getting the data it sought about reform efforts. By Sarah Owermohle

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser